EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Personalize statin therapy following acute ischemic stroke

Michael B. Brown

Drugs & Therapy Perspectives · 20.07.2026 · 42 (2) · 334-337

DOI: 10.1007/s40267-026-01268-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drugs & Therapy Perspectives, online erschienen am 20.07.2026. Verfasst von Michael B. Brown. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Statins are a cornerstone of secondary prevention following acute ischemic stroke (AIS). Widely used for their lipid-lowering effects, emerging evidence suggests the pleiotropic properties of statins provide a benefit in AIS management, including for patients with low baseline lipid levels. Established guidelines for statin therapy following AIS are inconsistent. Treatment optimization requires a personalised approach which considers stroke subtype and patient characteristics. Emerging strategies in statin care following AIS include novel drug-delivery systems improving bioavailability to the brain and combination therapies for patients with comorbid conditions or resistance to statin therapy.

Zitieren

APA

Brown, M. B. (2026). Personalize statin therapy following acute ischemic stroke. Drugs & Therapy Perspectives, 42(2), 334-337. https://doi.org/10.1007/s40267-026-01268-3

Vancouver

Brown MB. Personalize statin therapy following acute ischemic stroke. Drugs & Therapy Perspectives. 2026;42(2):334-337. doi:10.1007/s40267-026-01268-3

BibTeX
@article{Brown2026,
  author = {Brown, Michael B.},
  title = {Personalize statin therapy following acute ischemic stroke},
  journal = {Drugs & Therapy Perspectives},
  year = {2026},
  volume = {42},
  number = {2},
  pages = {334--337},
  doi = {10.1007/s40267-026-01268-3}
}
Kostenlos starten →